Hap Trading, LLC Galectin Therapeutics Inc Call Options Transaction History

Hap Trading, LLC

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 14, 2021	SELL	$1.96 - $2.57 $35,280 - $46,260	-18,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.24 - $2.87 $6,944 - $8,897	3,100 Added 20.81%	18,000 $8,000
Q3 2020 Nov 13, 2020	BUY	$2.53 - $3.64 $37,697 - $54,236	14,900 New	14,900 $9,000

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $123M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.